Key facts
- This page summarizes Laura A. Philips's Form 3 filing for Niki BioSolutions, Inc. (NIKI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jul 2026, 16:30.
Laura A. Philips - 20 Jul 2026 Form 3 Insider Report for Niki BioSolutions, Inc. (NIKI)
- Reporting relationship
- Director
- Issuer ticker
- NIKI
- Reported as of
- 20 Jul 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Laura A. Philips
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Laura A. Philips filed Form 3 for Niki BioSolutions, Inc. (NIKI) on 24 Jul 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001401312
Primary reporting owner
Philips Laura A
- Relationship
- Director
- Address
- C/O NIKI BIOSOLUTIONS, INC., 116 VILLAGE BOULEVARD, SUITE 200, PRINCETON
- Signature
- /s/ Laura A. Philips
- Signature date
- 24 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NIKI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,024
- Date
- 20 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.